{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:51:14Z","timestamp":1792515074279,"version":"4.5.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Myeloid-derived suppressor cells (MDSC) were first recognized over twenty years ago as a key immunomodulatory cell population. Since their initial identification, a growing body of literature points to the importance of MDSC as a heterogeneous, immunosuppressive cell population and as a therapeutic target in adults with cancer. MDSC are potent suppressors of T cells and Natural Killer (NK) cells and can be helpful or harmful to the host depending on the pathophysiology. For example, MDSC are beneficial in pregnancy and prevent spontaneous abortion by promoting maternal-fetal tolerance. Increased MDSC are also associated with improved outcomes in patients with graft vs. host disease by decreasing T cell-driven inflammation. However, MDSC can also be harmful and are known to be pathologic in adults with cancer and chronic infections by promoting tumor escape and impairing pathogen clearance, respectively. Despite the widespread recognition of the importance of MDSC and their immune suppression effects in adults, much less is known regarding the role of MDSC in children. Research investigating MDSC in children lags significantly behind adult studies. In fact, while over 5,000 publications on PubMed discuss MDSC in immune regulation, fewer than 50 of these publications focus specifically on their role in children. This review aims to summarize the existing literature on the role of MDSC in children and identify important directions for future research, including targeting these cells in the pediatric population to improve clinical outcomes.<\/jats:p>","DOI":"10.3389\/fped.2025.1525143","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:16:58Z","timestamp":1740640618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of myeloid-derived suppressor cells in children"],"prefix":"10.3389","volume":"13","author":[{"given":"Jordan","family":"Brauner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"B1","volume-title":"Basic Immunology. Functions and Disorders of the Immune System","author":"Abbas","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","article-title":"The terminology issue for myeloid-derived suppressor cells","volume":"67","author":"Gabrilovich","year":"2007","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1002\/jcp.26896","article-title":"Circulating myeloid-derived suppressor cells: an independent prognostic factor in patients with breast cancer","volume":"234","author":"Safarzadeh","year":"2019","journal-title":"J Cell Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The nature of myeloid-derived suppressor cells in the tumor microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1159\/000489830","article-title":"Myeloid-derived suppressor cells in infection: a general overview","volume":"10","author":"Medina","year":"2018","journal-title":"J Innate Immun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/toxins13100677","article-title":"Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments","volume":"13","author":"Ahmad-Mansour","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"210216","DOI":"10.1098\/rsob.210216","article-title":"Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection","volume":"11","author":"Yaseen","year":"2021","journal-title":"Open Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.omto.2019.08.005","article-title":"Immunotherapeutic challenges for pediatric cancers","volume":"15","author":"Hutzen","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1189\/jlb.5MA1116-453RR","article-title":"Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia","volume":"102","author":"Liu","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00262-018-2175-3","article-title":"Targeting myeloid-derived suppressor cells for cancer immunotherapy","volume":"67","author":"Liu","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B18","doi-asserted-by":"publisher","first-page":"584712","DOI":"10.3389\/fimmu.2020.584712","article-title":"Myeloid-derived suppressor cells in pregnancy and the neonatal period","volume":"11","author":"Kostlin-Gille","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1080391","DOI":"10.3389\/fimmu.2023.1080391","article-title":"Myeloidderived suppressor cells: escorts at the maternal-fetal interface","volume":"14","author":"Pang","year":"2023","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3389\/fimmu.2018.01098","article-title":"Granulocytic myeloid-derived suppressor cells (GR-MDSC) in breast milk (BM); GR-MDSC accumulate in human BM and modulate T-cell and monocyte function","volume":"9","author":"Kostlin","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/nu12092571","article-title":"Granulocytic myeloid-derived suppressor cells in breast milk (BM-MDSC) correlate with gestational age and postnatal age and are influenced by infant\u2019s sex","volume":"12","author":"Kostlin-Gille","year":"2020","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e107816","DOI":"10.1371\/journal.pone.0107816","article-title":"Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses","volume":"9","author":"Gervassi","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/cei.13059","article-title":"Granulocytic myeloid-derived suppressor cells (GR-MDSC) accumulate in cord blood of preterm infants and remain elevated during the neonatal period","volume":"191","author":"Schwarz","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nm.4467","article-title":"Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation","volume":"24","author":"He","year":"2018","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1096\/fj.201601083R","article-title":"In neonates S100A8\/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock","volume":"31","author":"Heinemann","year":"2017","journal-title":"FASEB J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/eji.201646621","article-title":"Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli","volume":"47","author":"Leiber","year":"2017","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2451149","DOI":"10.1002\/eji.202451149","article-title":"Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy","volume":"54","author":"Dietz","year":"2024","journal-title":"Eur J Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.3390\/ijms24097763","article-title":"Depletion of Ly6G-expressing neutrophilic cells leads to altered peripheral T-cell homeostasis and thymic development in neonatal mice","volume":"24","author":"Ruhle","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2250144","DOI":"10.1002\/eji.202250144","article-title":"HIF-1alpha targeted deletion in myeloid cells decreases MDSC accumulation and alters microbiome in neonatal mice","volume":"53","author":"Schwarz","year":"2023","journal-title":"Eur J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5114\/ceji.2018.81359","article-title":"The level of myeloid-derived suppressor cells positively correlates with regulatory T cells in the blood of children with transient hypogammaglobulinaemia of infancy","volume":"43","author":"Sieminska","year":"2018","journal-title":"Cent Eur J Immunol"},{"key":"B31","first-page":"104","article-title":"Novel immunotherapy targets for relapsed\/refractory B-ALL: a literature review","volume":"50","author":"White","year":"2024","journal-title":"J Assoc Genet Technol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15039","DOI":"10.1038\/s41598-021-94469-x","article-title":"Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia","volume":"11","author":"Zahran","year":"2021","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1479-5876-9-170","article-title":"Distinct signatures of the immune responses in low risk versus high risk neuroblastoma","volume":"9","author":"Gowda","year":"2011","journal-title":"J Transl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13045-021-01193-0","article-title":"Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma","volume":"14","author":"Tumino","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.4049\/jimmunol.1202144","article-title":"Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease","volume":"190","author":"Rieber","year":"2013","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcimb.2016.00167","article-title":"Pseudomonas aeruginosa airway infection recruits and modulates neutrophilic myeloid-derived suppressor cells","volume":"6","author":"Oz","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/eji.202048629","article-title":"Elevated monocytic myeloid-derived suppressor cells positively correlate with infection frequency in children with RRTIs","volume":"51","author":"Ji","year":"2021","journal-title":"Eur J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"893045","DOI":"10.3389\/fped.2022.893045","article-title":"Myeloid-derived suppressor cells and clinical outcomes in children with COVID-19","volume":"10","author":"Bline","year":"2022","journal-title":"Front Pediatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/eji.201646658","article-title":"Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed\/infected with Mycobacterium tuberculosis","volume":"47","author":"Du Plessis","year":"2017","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SHK.0000000000000217","article-title":"Innate immune function predicts the development of nosocomial infection in critically injured children","volume":"42","author":"Muszynski","year":"2014","journal-title":"Shock"},{"key":"B42","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/cc13980","article-title":"Early adaptive immune suppression in children with septic shock: a prospective observational study","volume":"18","author":"Muszynski","year":"2014","journal-title":"Crit Care"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1097\/PCC.0000000000003071","article-title":"Novel identification of myeloid-derived suppressor cells in children with septic shock","volume":"23","author":"Bline","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100848","DOI":"10.1016\/j.xcrm.2022.100848","article-title":"Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children","volume":"3","author":"Boribong","year":"2022","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6157385","DOI":"10.1155\/2022\/6157385","article-title":"MDSCs aggravate the asthmatic progression in children and OVA-allergic mice by regulating the Th1\/Th2\/Th17 responses","volume":"2022","author":"Lin","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e63775","DOI":"10.1371\/journal.pone.0063775","article-title":"Peripheral blood MDSCs, IL-10 and IL-12 in children with asthma and their importance in asthma development","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/mi.2016.47","article-title":"CD4(+) Th2 cells are directly regulated by IL-10 during allergic airway inflammation","volume":"10","author":"Coomes","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/0003489418812902","article-title":"Myeloid-derived suppressor cells and costimulatory molecules in children with allergic rhinitis","volume":"128","author":"Zahran","year":"2019","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: a comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur Respir J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.rmed.2009.10.004","article-title":"T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension","volume":"104","author":"Austin","year":"2010","journal-title":"Respir Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.11-0205","article-title":"Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension","volume":"141","author":"Yeager","year":"2012","journal-title":"Chest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clim.2014.04.006","article-title":"Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of type 1 diabetes mellitus patients","volume":"153","author":"Whitfield-Larry","year":"2014","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0242092","DOI":"10.1371\/journal.pone.0242092","article-title":"Myeloid-derived suppressor cells in type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms","volume":"15","author":"Grohova","year":"2020","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the expanded programme on immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/vaccines10081367","article-title":"Current vaccine platforms in enhancing T-cell response","volume":"10","author":"Ura","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.4049\/jimmunol.0903348","article-title":"Mycobacterium bovis bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production","volume":"184","author":"Martino","year":"2010","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.4161\/hv.29847","article-title":"Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination","volume":"10","author":"Fernandez","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"B58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/JLB.5A0420-281R","article-title":"Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infants","volume":"110","author":"Kidzeru","year":"2021","journal-title":"J Leukoc Biol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1525143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:17:03Z","timestamp":1740640623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1525143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":58,"alternative-id":["10.3389\/fped.2025.1525143"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1525143","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"article-number":"1525143"}}